Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Joslin Diabetes Center is a Boston-based nonprofit diabetes specialty center focused on diabetes clinical care, translational and basic research, and professional and patient education. It is a Harvard Medical School affiliate and part of Beth Israel Lahey Health, with a long-standing emphasis on type 1 diabetes, type 2 diabetes, obesity, and diabetes complications. The organization operates specialty clinical programs and conducts investigator-led research and clinical trials rather than functioning like a venture-backed therapeutic biotech with a discrete drug pipeline. Its activities span endocrinology care, eye and kidney complications, pregnancy and pediatric diabetes, diabetes technology, and metabolic disease research. Joslin is best understood as a leading diabetes-focused healthcare and research institution rather than a drug development company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Joslin Institute.